Chang-Sung Koh

520 citations
19 papers · 428 indexed · h-index 11
Topics
Multiple Sclerosis Research Studies (8 papers)Immunotherapy and Immune Responses (5 papers)Immune Cell Function and Interaction (3 papers)

In The Last Decade

Chang-Sung Koh

19 papers receiving 421 citations

Peers

Chang-Sung Koh
Comparison fields: 5 of 68
  • Immunology 218
  • Pathology and Forensic Medicine 133
  • Molecular Biology 90
  • Oncology 75
  • Rheumatology 57
Replace Ben J. E. Raveney with:
Ben J. E. Raveney Japan
S. Galgani Italy
David D. Hebrink United States
Jesse Huang Sweden
B. Blanchard France
M Spatz United States
Raffaele Murru Italy
Silvia Seubert Germany
Martina Kunkl Italy
Teodora Niculescu United States
Chang-Sung Koh relative to Ben J. E. Raveney Japan Ben J. E. Raveney's profile →
Citations per field
00.5×1.7×
Ben J. E. Raveney · 1×
Citations per year

Countries citing papers authored by Chang-Sung Koh

Since Specialization
Citations

This map shows the geographic impact of Chang-Sung Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang-Sung Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang-Sung Koh more than expected).

Fields of papers citing papers by Chang-Sung Koh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang-Sung Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang-Sung Koh. The network helps show where Chang-Sung Koh may publish in the future.

Co-authorship network of co-authors of Chang-Sung Koh

This figure shows the co-authorship network connecting the top 25 collaborators of Chang-Sung Koh. A scholar is included among the top collaborators of Chang-Sung Koh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang-Sung Koh. Chang-Sung Koh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 7
2 3
3 12
4 12
5 7
6 3
7 36
8 5
9 4
10 52
11 10
12 53
13 32
14 9
15 19
16 98
17 51
18 1
19 14

About Chang-Sung Koh

Chang-Sung Koh is a scholar working on Immunology, Immunology and Allergy and Pathology and Forensic Medicine, having authored 19 papers that have together received 428 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (8 papers), Immunotherapy and Immune Responses (5 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Immunology (218 citations), Pathology and Forensic Medicine (133 citations) and Neurology (46 citations). Chang-Sung Koh has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Byung‐Soo Kim, Motoki Ichikawa, Yuji Inaba, Atsushi Inoue, Makoto Itoh, Hiroyuki Yahikozawa, Robert L. Yauch, Joann P. Palma, Atsushi Komiyama and Hidenori Matsuo. Their work appears in journals such as Journal of Virology, Brain Research and Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026